However, mutations in various genes related to TKs were detected in the tumor samples (JAK3, NRAS, NTRK2, NF1, SETD2) suggesting frequent alteration of TK pathways for neuroendocrine neoplasms. Here, SETD2 is linked to neuroendocrine neoplasm.